Rabeprazole is sold under the trade name AcipHex [1].
What are other uses for AcipHex?
AcipHex is prescribed to treat erosive esophagitis, which is a damage to the esophagus caused by stomach acid. It is also used to maintain healing of erosive esophagitis and to treat heartburn associated with gastroesophageal reflux disease (GERD) [2].
How does rabeprazole work?
Rabeprazole is a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced in the stomach [2]. This reduction in stomach acid helps to heal damage to the esophagus and relieve symptoms like heartburn [2].
When does the patent for AcipHex expire?
The patent for AcipHex has expired, allowing for the production of generic versions of rabeprazole [3]. The last expiring patent for rabeprazole sodium was in 2017 [4].
Are there generic versions of AcipHex available?
Yes, generic rabeprazole is available [3]. The availability of generic versions can lead to lower costs for consumers [3].
How does rabeprazole compare to other proton pump inhibitors?
Rabeprazole is one of several proton pump inhibitors used to treat acid-related stomach conditions. Other common PPIs include omeprazole (Prilosec), lansoprazole (Prevacid), pantoprazole (Protonix), and esomeprazole (Nexium) [5]. While all PPIs work by reducing stomach acid, they may have slight differences in how quickly they work or how they are metabolized by the body [5].
What are the potential side effects of rabeprazole?
Common side effects of rabeprazole can include diarrhea, nausea, vomiting, abdominal pain, headache, and dizziness [2]. Less common side effects may also occur [2]. Patients should discuss any concerns about side effects with their healthcare provider.
Who manufactures AcipHex?
AcipHex is manufactured by Eisai Inc. [6].
Sources:
[1] https://www.drugs.com/imprints/aciphex-44046.html
[2] https://www.aciphex.com/
[3] https://www.drugpatentwatch.com/drug/rabeprazole
[4] https://www.drugpatentwatch.com/drug/rabeprazole-sodium
[5] https://www.mayoclinic.org/drugs-supplements/rabeprazole-oral-route-parenteral-route/description/drg-20067887
[6] https://www.drugbank.ca/drugs/AY74415